Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil

Figure 3

Time from second-line cART initiation to virologic failure stratified by anchor drug received for all patients (top, log-rank test p = 0.002), the sub-group of patients with an undetectable viral load (middle, log-rank test p < 0.002), and the sub-group of patients with detectable viral load (bottom, log-rank test p = 0.70), IPEC cohort, 2000-2013.

Back to article page